Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 55

1.

Pgp3 seroprevalence and associations with active trachoma and ocular Chlamydia trachomatis infection in Malawi: cross-sectional surveys in six evaluation units.

Burr SE, Hart J, Samikwa L, Chaima D, Cooley G, Martin D, Masika M, Solomon AW, Bailey RL, Kalua K.

PLoS Negl Trop Dis. 2019 Oct 28;13(10):e0007749. doi: 10.1371/journal.pntd.0007749. eCollection 2019 Oct.

2.

Conjunctival Microbiome-Host Responses Are Associated With Impaired Epithelial Cell Health in Both Early and Late Stages of Trachoma.

Pickering H, Palmer CD, Houghton J, Makalo P, Joof H, Derrick T, Goncalves A, Mabey DCW, Bailey RL, Burton MJ, Roberts CH, Burr SE, Holland MJ.

Front Cell Infect Microbiol. 2019 Aug 21;9:297. doi: 10.3389/fcimb.2019.00297. eCollection 2019.

3.

Population-based analysis of ocular Chlamydia trachomatis in trachoma-endemic West African communities identifies genomic markers of disease severity.

Last AR, Pickering H, Roberts CH, Coll F, Phelan J, Burr SE, Cassama E, Nabicassa M, Seth-Smith HMB, Hadfield J, Cutcliffe LT, Clarke IN, Mabey DCW, Bailey RL, Clark TG, Thomson NR, Holland MJ.

Genome Med. 2018 Feb 26;10(1):15. doi: 10.1186/s13073-018-0521-x.

4.

Evaluation of a Chlamydia trachomatis-specific, commercial, real-time PCR for use with ocular swabs.

Pickering H, Holland MJ, Last AR, Burton MJ, Burr SE.

Parasit Vectors. 2018 Feb 20;11(1):102. doi: 10.1186/s13071-018-2686-y.

5.

The impact of a single round of community mass treatment with azithromycin on disease severity and ocular Chlamydia trachomatis load in treatment-naïve trachoma-endemic island communities in West Africa.

Last AR, Burr SE, Harding-Esch E, Cassama E, Nabicassa M, Roberts CH, Mabey DCW, Holland MJ, Bailey RL.

Parasit Vectors. 2017 Dec 28;10(1):624. doi: 10.1186/s13071-017-2566-x.

6.

Does azithromycin given to women in labour decrease ocular bacterial infection in neonates? A double-blind, randomized trial.

Burr SE, Camara B, Oluwalana C, Bojang E, Bottomley C, Bojang A, Bailey RL, D'Alessandro U, Roca A.

BMC Infect Dis. 2017 Dec 28;17(1):799. doi: 10.1186/s12879-017-2909-4.

7.

An outbreak of acute haemorrhagic conjunctivitis associated with coxsackievirus A24 variant in The Gambia, West Africa.

Burr SE, Sillah A, Joof H, Bailey RL, Holland MJ.

BMC Res Notes. 2017 Dec 6;10(1):692. doi: 10.1186/s13104-017-3007-9.

8.

Serology reflects a decline in the prevalence of trachoma in two regions of The Gambia.

Migchelsen SJ, Sepúlveda N, Martin DL, Cooley G, Gwyn S, Pickering H, Joof H, Makalo P, Bailey R, Burr SE, Mabey DCW, Solomon AW, Roberts CH.

Sci Rep. 2017 Nov 8;7(1):15040. doi: 10.1038/s41598-017-15056-7.

9.

Genome-wide profiling of humoral immunity and pathogen genes under selection identifies immune evasion tactics of Chlamydia trachomatis during ocular infection.

Pickering H, Teng A, Faal N, Joof H, Makalo P, Cassama E, Nabicassa M, Last AR, Burr SE, Rowland-Jones SL, Thomson NR, Roberts CH, Mabey DCW, Bailey RL, Hayward RD, de la Maza LM, Holland MJ.

Sci Rep. 2017 Aug 29;7(1):9634. doi: 10.1038/s41598-017-09193-2.

10.

Population-based prevalence survey of follicular trachoma and trachomatous trichiasis in the Casamance region of Senegal.

Harding-Esch EM, Kadimpeul J, Sarr B, Sane A, Badji S, Laye M, Sillah A, Burr SE, MacLeod D, Last AR, Holland MJ, Mabey DC, Bailey RL.

BMC Public Health. 2017 Jul 26;18(1):62. doi: 10.1186/s12889-017-4605-0. Erratum in: BMC Public Health. 2017 Sep 22;17 (1):736.

11.

Short-term increase in prevalence of nasopharyngeal carriage of macrolide-resistant Staphylococcus aureus following mass drug administration with azithromycin for trachoma control.

Bojang E, Jafali J, Perreten V, Hart J, Harding-Esch EM, Sillah A, Mabey DC, Holland MJ, Bailey RL, Roca A, Burr SE.

BMC Microbiol. 2017 Mar 28;17(1):75. doi: 10.1186/s12866-017-0982-x.

12.

Profiling and validation of individual and patterns of Chlamydia trachomatis-specific antibody responses in trachomatous trichiasis.

Pickering H, Burr SE, Derrick T, Makalo P, Joof H, Hayward RD, Holland MJ.

Parasit Vectors. 2017 Mar 13;10(1):143. doi: 10.1186/s13071-017-2078-8.

13.

Cross-Sectional Surveys of the Prevalence of Follicular Trachoma and Trichiasis in The Gambia: Has Elimination Been Reached?

Burr SE, Sillah A, Sanou AS, Wadagni AC, Hart J, Harding-Esch EM, Kanyi S, Bailey RL.

PLoS Negl Trop Dis. 2016 Sep 19;10(9):e0004906. doi: 10.1371/journal.pntd.0004906. eCollection 2016 Sep.

14.

Design of an Immersion Vaccine Against Aeromonad Septicemia in Perch (Perca fluviatilis L.).

Frey J, Burr SE, Wahli T.

Methods Mol Biol. 2016;1404:203-9. doi: 10.1007/978-1-4939-3389-1_14.

PMID:
27076300
15.

Inverse relationship between microRNA-155 and -184 expression with increasing conjunctival inflammation during ocular Chlamydia trachomatis infection.

Derrick T, Last AR, Burr SE, Roberts CH, Nabicassa M, Cassama E, Bailey RL, Mabey DC, Burton MJ, Holland MJ.

BMC Infect Dis. 2016 Feb 3;16:60. doi: 10.1186/s12879-016-1367-8.

16.

Conjunctival fibrosis and the innate barriers to Chlamydia trachomatis intracellular infection: a genome wide association study.

Roberts Ch, Franklin CS, Makalo P, Joof H, Sarr I, Mahdi OS, Sillah A, Bah M, Payne F, Jeffreys AE, Bottomley W, Natividad A, Molina-Gonzalez S, Burr SE, Preston M, Kwiatkowski D, Rockett KA, Clark TG, Burton MJ, Mabey DC, Bailey R, Barroso I, Holland MJ.

Sci Rep. 2015 Nov 30;5:17447. doi: 10.1038/srep17447.

17.

Trachoma and Ocular Chlamydial Infection in the Era of Genomics.

Derrick T, Roberts Ch, Last AR, Burr SE, Holland MJ.

Mediators Inflamm. 2015;2015:791847. doi: 10.1155/2015/791847. Epub 2015 Sep 3. Review.

18.

The conjunctival microbiome in health and trachomatous disease: a case control study.

Zhou Y, Holland MJ, Makalo P, Joof H, Roberts CH, Mabey DC, Bailey RL, Burton MJ, Weinstock GM, Burr SE.

Genome Med. 2014 Nov 15;6(11):99. doi: 10.1186/s13073-014-0099-x. eCollection 2014.

19.

Anthropometric indices of Gambian children after one or three annual rounds of mass drug administration with azithromycin for trachoma control.

Burr SE, Hart J, Edwards T, Harding-Esch EM, Holland MJ, Mabey DC, Sillah A, Bailey RL.

BMC Public Health. 2014 Nov 18;14:1176. doi: 10.1186/1471-2458-14-1176.

20.

Non-participation during azithromycin mass treatment for trachoma in The Gambia: heterogeneity and risk factors.

Edwards T, Allen E, Harding-Esch EM, Hart J, Burr SE, Holland MJ, Sillah A, West SK, Mabey D, Bailey R.

PLoS Negl Trop Dis. 2014 Aug 28;8(8):e3098. doi: 10.1371/journal.pntd.0003098. eCollection 2014 Aug.

21.

Mass administration of azithromycin and Streptococcus pneumoniae carriage: cross-sectional surveys in the Gambia.

Burr SE, Milne S, Jafali J, Bojang E, Rajasekhar M, Hart J, Harding-Esch EM, Holland MJ, Mabey DC, Sillah A, Bailey RL, Roca A.

Bull World Health Organ. 2014 Jul 1;92(7):490-8. doi: 10.2471/BLT.13.133462. Epub 2014 Apr 29.

22.

Risk factors for active trachoma and ocular Chlamydia trachomatis infection in treatment-naïve trachoma-hyperendemic communities of the Bijagós Archipelago, Guinea Bissau.

Last AR, Burr SE, Weiss HA, Harding-Esch EM, Cassama E, Nabicassa M, Mabey DC, Holland MJ, Bailey RL.

PLoS Negl Trop Dis. 2014 Jun 26;8(6):e2900. doi: 10.1371/journal.pntd.0002900. eCollection 2014 Jun.

23.

Conjunctival scarring in trachoma is associated with the HLA-C ligand of KIR and is exacerbated by heterozygosity at KIR2DL2/KIR2DL3.

Roberts CH, Molina S, Makalo P, Joof H, Harding-Esch EM, Burr SE, Mabey DC, Bailey RL, Burton MJ, Holland MJ.

PLoS Negl Trop Dis. 2014 Mar 20;8(3):e2744. doi: 10.1371/journal.pntd.0002744. eCollection 2014 Mar.

24.

Will droplet digital PCR become the test of choice for detecting and quantifying ocular Chlamydia trachomatis infection? Maybe.

Roberts CH, Last A, Burr SE, Bailey RL, Mabey DC, Holland MJ.

Expert Rev Mol Diagn. 2014 Apr;14(3):253-6. doi: 10.1586/14737159.2014.897609. No abstract available.

25.

Effect of azithromycin mass drug administration for trachoma on spleen rates in Gambian children.

Hart JD, Edwards T, Burr SE, Harding-Esch EM, Takaoka K, Holland MJ, Sillah A, Mabey DC, Bailey RL.

Trop Med Int Health. 2014 Feb;19(2):207-11. doi: 10.1111/tmi.12234. Epub 2014 Jan 17.

26.

Plasmid copy number and disease severity in naturally occurring ocular Chlamydia trachomatis infection.

Last AR, Roberts Ch, Cassama E, Nabicassa M, Molina-Gonzalez S, Burr SE, Mabey DC, Bailey RL, Holland MJ.

J Clin Microbiol. 2014 Jan;52(1):324-7. doi: 10.1128/JCM.02618-13. Epub 2013 Nov 6.

27.

Follicular trachoma and trichiasis prevalence in an urban community in The Gambia, West Africa: is there a need to include urban areas in national trachoma surveillance?

Quicke E, Sillah A, Harding-Esch EM, Last A, Joof H, Makalo P, Bailey RL, Burr SE.

Trop Med Int Health. 2013 Nov;18(11):1344-52. doi: 10.1111/tmi.12182. Epub 2013 Sep 6.

28.

Antigens of the type-three secretion system of Aeromonas salmonicida subsp. salmonicida prevent protective immunity in rainbow trout.

Bergh PV, Burr SE, Benedicenti O, von Siebenthal B, Frey J, Wahli T.

Vaccine. 2013 Oct 25;31(45):5256-61. doi: 10.1016/j.vaccine.2013.08.057. Epub 2013 Sep 5.

29.

Association between ocular bacterial carriage and follicular trachoma following mass azithromycin distribution in The Gambia.

Burr SE, Hart JD, Edwards T, Baldeh I, Bojang E, Harding-Esch EM, Holland MJ, Lietman TM, West SK, Mabey DC, Sillah A, Bailey RL.

PLoS Negl Trop Dis. 2013 Jul 25;7(7):e2347. doi: 10.1371/journal.pntd.0002347. Print 2013.

30.

Mass treatment with azithromycin for trachoma: when is one round enough? Results from the PRET Trial in the Gambia.

Harding-Esch EM, Sillah A, Edwards T, Burr SE, Hart JD, Joof H, Laye M, Makalo P, Manjang A, Molina S, Sarr-Sissoho I, Quinn TC, Lietman T, Holland MJ, Mabey D, West SK, Bailey R; Partnership for Rapid Elimination of Trachoma (PRET) study group.

PLoS Negl Trop Dis. 2013 Jun 13;7(6):e2115. doi: 10.1371/journal.pntd.0002115. Print 2013. Erratum in: PLoS Negl Trop Dis. 2013 Jun;7(6). doi:10.1371/annotation/0bae8b34-5ae7-4044-a071-8d88d520a01b.

31.

Development and evaluation of a next-generation digital PCR diagnostic assay for ocular Chlamydia trachomatis infections.

Roberts CH, Last A, Molina-Gonzalez S, Cassama E, Butcher R, Nabicassa M, McCarthy E, Burr SE, Mabey DC, Bailey RL, Holland MJ.

J Clin Microbiol. 2013 Jul;51(7):2195-203. doi: 10.1128/JCM.00622-13. Epub 2013 May 1.

32.

Conjunctival MicroRNA expression in inflammatory trachomatous scarring.

Derrick T, Roberts Ch, Rajasekhar M, Burr SE, Joof H, Makalo P, Bailey RL, Mabey DC, Burton MJ, Holland MJ.

PLoS Negl Trop Dis. 2013;7(3):e2117. doi: 10.1371/journal.pntd.0002117. Epub 2013 Mar 14.

33.

Biogeography of the ecosystems of the healthy human body.

Zhou Y, Gao H, Mihindukulasuriya KA, La Rosa PS, Wylie KM, Vishnivetskaya T, Podar M, Warner B, Tarr PI, Nelson DE, Fortenberry JD, Holland MJ, Burr SE, Shannon WD, Sodergren E, Weinstock GM.

Genome Biol. 2013 Jan 14;14(1):R1. doi: 10.1186/gb-2013-14-1-r1.

34.

Heterogeneity of Aeromonas populations in wild and farmed perch, Perca fluviatilis L.

Burr SE, Goldschmidt-Clermont E, Kuhnert P, Frey J.

J Fish Dis. 2012 Aug;35(8):607-13. doi: 10.1111/j.1365-2761.2012.01388.x. Epub 2012 May 24. No abstract available.

PMID:
22620858
35.

Evaluating the frequency of bacterial co-infections in children recruited into a malaria pathogenesis study in The Gambia, West Africa using molecular methods.

Edwards MD, Morris GA, Burr SE, Walther M.

Mol Cell Probes. 2012 Aug;26(4):151-8. doi: 10.1016/j.mcp.2012.04.003. Epub 2012 Apr 21.

PMID:
22548974
36.

Active trachoma is associated with increased conjunctival expression of IL17A and profibrotic cytokines.

Burton MJ, Ramadhani A, Weiss HA, Hu V, Massae P, Burr SE, Shangali W, Holland MJ, Mabey DC, Bailey RL.

Infect Immun. 2011 Dec;79(12):4977-83. doi: 10.1128/IAI.05718-11. Epub 2011 Sep 12.

37.

What is causing active trachoma? The role of nonchlamydial bacterial pathogens in a low prevalence setting.

Burton MJ, Hu VH, Massae P, Burr SE, Chevallier C, Afwamba IA, Courtright P, Weiss HA, Mabey DC, Bailey RL.

Invest Ophthalmol Vis Sci. 2011 Jul 29;52(8):6012-7. doi: 10.1167/iovs.11-7326.

38.

Trachoma prevalence and associated risk factors in the gambia and Tanzania: baseline results of a cluster randomised controlled trial.

Harding-Esch EM, Edwards T, Mkocha H, Munoz B, Holland MJ, Burr SE, Sillah A, Gaydos CA, Stare D, Mabey DC, Bailey RL, West SK; PRET Partnership.

PLoS Negl Trop Dis. 2010 Nov 2;4(11):e861. doi: 10.1371/journal.pntd.0000861.

39.

Enhanced chloroplast transgene expression in a nuclear mutant of Chlamydomonas.

Michelet L, Lefebvre-Legendre L, Burr SE, Rochaix JD, Goldschmidt-Clermont M.

Plant Biotechnol J. 2011 Jun;9(5):565-74. doi: 10.1111/j.1467-7652.2010.00564.x. Epub 2010 Aug 31.

40.

Pseudomonas chlororaphis subsp. piscium subsp. nov., isolated from freshwater fish.

Burr SE, Gobeli S, Kuhnert P, Goldschmidt-Clermont E, Frey J.

Int J Syst Evol Microbiol. 2010 Dec;60(Pt 12):2753-7. doi: 10.1099/ijs.0.011692-0. Epub 2010 Jan 8.

PMID:
20061493
41.

Aeromonas salmonicida subsp. salmonicida type strain does not possess a type III secretion system.

Burr SE, Frey J.

J Clin Microbiol. 2009 Sep;47(9):3062-3. doi: 10.1128/JCM.00749-09. Epub 2009 Jun 24. No abstract available.

42.

Pseudomonas chlororaphis strain JF3835 reduces mortality of juvenile perch, Perca fluviatilis L., caused by Aeromonas sobria.

Gobeli S, Goldschmidt-Clermont E, Frey J, Burr SE.

J Fish Dis. 2009 Jul;32(7):597-602. doi: 10.1111/j.1365-2761.2009.01021.x. Epub 2009 May 20.

PMID:
19476558
43.

The AsaP1 peptidase of Aeromonas salmonicida subsp. achromogenes is a highly conserved deuterolysin metalloprotease (family M35) and a major virulence factor.

Arnadottir H, Hvanndal I, Andresdottir V, Burr SE, Frey J, Gudmundsdottir BK.

J Bacteriol. 2009 Jan;191(1):403-10. doi: 10.1128/JB.00847-08. Epub 2008 Oct 24.

44.

Identification of bacteria from the normal flora of perch, Perca fluviatilis L., and evaluation of their inhibitory potential towards Aeromonas species.

Goldschmidt-Clermont E, Wahli T, Frey J, Burr SE.

J Fish Dis. 2008 May;31(5):353-9. doi: 10.1111/j.1365-2761.2008.00912.x. Epub 2008 Mar 19.

PMID:
18355180
45.

Analysis of type III effector genes in typical and atypical Aeromonas salmonicida.

Burr SE, Frey J.

J Fish Dis. 2007 Nov;30(11):711-4. No abstract available.

PMID:
17958615
46.

Aeromonas exoenzyme T of Aeromonas salmonicida is a bifunctional protein that targets the host cytoskeleton.

Fehr D, Burr SE, Gibert M, d'Alayer J, Frey J, Popoff MR.

J Biol Chem. 2007 Sep 28;282(39):28843-52. Epub 2007 Jul 25.

47.

Alternative host model to evaluate Aeromonas virulence.

Froquet R, Cherix N, Burr SE, Frey J, Vilches S, Tomas JM, Cosson P.

Appl Environ Microbiol. 2007 Sep;73(17):5657-9. Epub 2007 Jul 6.

48.

AopP, a type III effector protein of Aeromonas salmonicida, inhibits the NF-kappaB signalling pathway.

Fehr D, Casanova C, Liverman A, Blazkova H, Orth K, Dobbelaere D, Frey J, Burr SE.

Microbiology. 2006 Sep;152(Pt 9):2809-18.

PMID:
16946275
49.

Attenuated virulence of an Aeromonas salmonicida subsp. salmonicida type III secretion mutant in a rainbow trout model.

Burr SE, Pugovkin D, Wahli T, Segner H, Frey J.

Microbiology. 2005 Jun;151(Pt 6):2111-8.

PMID:
15942017
50.

Aeromonas sobria, a causative agent of disease in farmed perch, Perca fluviatilis L.

Wahli T, Burr SE, Pugovkin D, Mueller O, Frey J.

J Fish Dis. 2005 Mar;28(3):141-50.

PMID:
15752274

Supplemental Content

Support Center